EnGene Holdings Names Ryan Daws Chief Financial Officer
By Colin Kellaher EnGene Holdings has named Ryan Daws chief financial officer and head of business development for the clinical-stage genetic-medicines...
Source: marketwatch.com
Stay updated with breaking news from Ryan Daws. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Colin Kellaher EnGene Holdings has named Ryan Daws chief financial officer and head of business development for the clinical-stage genetic-medicines...
BOSTON and MONTREAL, Nov. 29, 2023 /PRNewswire/ - enGene Holdings Inc. , a clinical-stage genetic medicines company whose lead program is in a pivotal study for BCG-unresponsive non-muscle...